Background--Vasovagal reflex is the most common form of syncope, but the pathophysiological mechanisms that initiate the reflex are not well understood. We aimed to study supine and early orthostatic levels of the neurohormones involved in control of circulatory homeostasis in relation to the onset of tilt-induced vasovagal syncope (VVS).
1
Currently, it is unclear whether neurohormones that are involved in cardiovascular homeostasis contribute to VVS pathophysiology. Further, it is uncertain whether neurohormones contribute directly to triggering VVS or if they instead reflect a compensatory mechanism caused by hemodynamic stress. 3 Defining the neuroendocrine pathophysiology of VVS may determine potential targets for therapy or diagnostic testing. Previous studies have indicated that resting and orthostatic levels of various neurohormones, such as catecholamines, vasopressin, adrenomedullin, and natriuretic peptides are associated with vasovagal reflex susceptibility. [4] [5] [6] [7] Conversely, in the setting of HUT-induced VVS, a decrease in circulating levels of atrial natriuretic peptide is associated with VVS. Additionally, increased levels of vasopressin and epinephrine have been reported before VVS. 6, 8, 9 However, it is unclear whether or not the magnitude of neuroendocrine changes during orthostatic challenge correlates with VVS susceptibility. Consequently, we studied changes in supine and early orthostatic levels of neurohormones involved in control of circulatory homeostasis with the goal of assessing their relation to the onset of the tilt-induced VVS reflex. Utilizing the concept that a shorter time to syncope during HUT reflected greater VVS susceptibility, 8 we hypothesized that greater neuroendocrine changes during HUT would correlate with a shorter time to syncope.
Materials and Methods
The data that support the findings of this study are available from the corresponding author on reasonable request.
Patient Population
The present study was conducted from August 27, 2008 through December 31, 2014 as a part of the ongoing SYSTEMA (Syncope Study of Unselected Population in Malm€ o) project. 6, 10 Patients with unexplained syncope were referred to the tertiary syncope unit at Sk ane University Hospital in Malm€ o from primary care and hospitals in southern Sweden. The syncope unit is the only referral center in the catchment area of about 1.5 million citizens. Unexplained syncope was defined as transient loss of consciousness without established diagnosis after the initial evaluation. During the study period, 1141 consecutive patients (60.6% women; age 53AE22 years) were enrolled. Of these, 827 patients had blood samples collected from an intravenous line obtained both in supine position and after 3 minutes of HUT as per the initial SYSTEMA study protocol. 6 Among patients with collected blood samples, 466 (56.3%) were diagnosed with VVS according to the current syncope management guidelines, that is, a positive HUT with a typical pattern of sudden-onset hypotension and bradycardia accompanied by the reproduction of characteristic symptoms. 1,2 Using a concept previously applied by Kohno and collaborators, 8 we identified 173 patients (20.9%) who developed VVS during the drug-free HUT; of these a total of 161 patients had no missing values and were analyzed. Figure 1 illustrates the flowchart of the study.
Examination Protocol and Blood Samples
Patients were instructed to take their regular medications and fast for 2 hours before the test but were allowed to drink water. Data on past medical history and the characteristics of syncope-related symptoms were collected using a selfadministered questionnaire. The examination included a standard HUT according to the Italian protocol, 11 that is, a drug-free HUT phase of 20 minutes or until syncope occurred, followed by an optional 15 minutes of drug-potentiated phase with sublingual 400 lg nitroglycerin, if the drug-free phase was negative. Beat-to-beat blood pressure and electrocardiogram were monitored continuously by a validated noninvasive method (Nexfin monitor; BMEYE, Amsterdam, the Netherlands). 12 Blood samples were collected from an intravenous line installed on the left arm %10 minutes before the test. Blood samples were obtained both in a supine position and after 3 minutes of HUT. The time point of 3 minutes of HUT for the assessment of circulating neurohormones was based on previous physiological studies 13 indicating that the thoracic blood volume displacement to the lower body, heart rate, and the total peripheral resistance usually reach a steady state after 3 minutes of active standing or HUT, which implies that the initial neurohormonal responses are fully developed at that time. The first author (P.T.) performed an offline post hoc analysis of HUT records and retrieved the time-tosyncope variable for each patient with VVS during the drug-free HUT.
Neuroendocrine Measurements
The assessment of plasma neurohormone levels has been described previously. 6 Briefly, we analyzed baseline and 3-minute HUT levels of epinephrine, norepinephrine, C-terminal pro-arginine vasopressin (CT-proAVP), C-terminal pro-endothelin-1, midregional fragments of pro-atrial natriuretic peptide, and pro-adrenomedullin
Clinical Perspective
What Is New?
• This study highlights that age, increased supine systolic blood pressure, and higher level of pro-adrenomedullin are associated with later onset of vasovagal syncope during tilt testing, whereas greater increase of tilt-induced epinephrine and vasopressin release correlate with shorter time to syncope.
What Are the Clinical Implications?
• Characterization of the neuroendocrine profile in vasovagal syncope may assist in the development of effective strategies for syncope prevention in patients experiencing recurrent and unpredicted events.
(MR-proADM). The analyzed nonactive peptides (CT-proAVP, Cterminal pro-endothelin-1, midregional pro-atrial natriuretic peptide, and MR-proADM) are generated from the pro-neurohormone molecule in the ratio 1:1 in relation to the active neuropeptide and are more stable than their corresponding biologically active substances. We used high-performance liquid chromatography with a fluorescence detection method for catecholamines 14 and ThermoScientific BRAHMS assays (BRAHMS GmbH, ThermoFisher Scientific, Hennigsdorf, Germany) for measurement of CT-proAVP, C-terminal pro-endothelin-1, midregional pro-atrial natriuretic peptide, and MR-proADM, according to the manufacturer's instructions. 15, 16 The study protocol was approved by the regional ethical review board in Lund, Sweden (reference no 82/2008). Written informed consent was obtained from all study participants.
Statistical Analysis
The main characteristics of the study population are presented as mean and standard deviation for normally distributed continuous variables, as median and interquartile range for non-normally distributed variables, and percentages for categorical variables.
We applied a linear regression model adjusted for age and sex. We entered time to syncope while in the 70°head-up position as the dependent variable and neurohormone concentration at baseline, after 3-minutes HUT, and D value (3-minute HUT minus baseline) as the independent variables. All patients who developed VVS before the 3-minute time point during HUT were excluded from the orthostatic change analyses because the protocol called for the blood sample to be collected at 3 minutes of upright posture. Neurohormone levels were log-transformed and standardized (expressed per 1 standard deviation). The normality assumption of residuals for each linear model was checked by histograms and normal quantile-quantile plots of residuals. The plots showed no violation of the normality assumption. Statistical analyses were carried out using IBM SPSS Statistics version 25 (SPSS Inc, Chicago, IL). All tests were 2-sided, and P<0.05 was considered significant.
Results

Study Population Characteristics
The main characteristics of the study population are presented in Table 1 . The study population included 161 patients with tilt-induced VVS during drug-free HUT (56.3% women; age 45AE21 years). The mean time to syncope was 11AE7 minutes. Ten patients were tilted down due to syncope 11 ie, a 20-minute drug-free HUT phase followed by 15-minute nitroglycerin-potentiated phase, 872 had blood samples collected while supine and after 3 minutes of HUT. A total of 173 patients developed and reproduced vasovagal syncope during the drug-free phase. Of these, 161 had no missing values and were included in the analyses of 6 neurohormones vs time to syncope onset during the drug-free HUT phase. SYSTEMA indicates Syncope Study of Unselected Population in Malm€ o.
before the upright blood sample could be collected, that is, within the first 3 minutes of HUT and were, therefore, excluded from the analysis.
Older age (b=0.13; SE=0.03, P<0.001) and higher supine systolic blood pressure (b=0.06; SE=0.03, P=0.02) but neither sex (b=0.57; SE=1.12, P=0.61) nor higher supine heart rate (b=0.01; SE=0.05, P=0.88) predicted longer time to syncope.
Neurohormones and Time to Syncope
The overall neurohormone plasma concentration levels are shown in Table 2 . As can be seen in Table 3 , higher baseline supine MR-proADM predicted longer time to syncope (b=2.31; SE=0.77, P=0.003), whereas other baseline supine neurohormones were not associated with time to syncope. On the other hand, increased levels of epinephrine (b=À2.13; SE=0.59, P<0.001) and CT-proAVP (b=À1.39; SE=0.68, P=0.043) after 3 minutes of HUT were predictive of shorter time to syncope, whereas higher 3-minute MR-proADM (b=1.76; SE=0.82, P=0.035) was associated with prolonged time to syncope.
Supine MR-proADM, D (ie, 3-minute HUT minus supine) epinephrine, and D CT-proAVP concentrations were significantly different across tertiles of the time-to-syncope variable (Figures 2 through 4) .
Discussion
This study examined the hypothesis that greater neuroendocrine changes during a head-up tilt test would correlate with a shorter time to initiation of the VVS reflex. We observed that a greater presyncopal increase in epinephrine and CT-pro-AVP during tilt testing correlated significantly with shorter time to onset of VVS. Further, higher supine MR-pro-ADM was associated with a longer time to HUTinduced VVS, as also were older age and higher systolic blood pressure.
Epinephrine
Previous reports have demonstrated higher orthostatic levels of epinephrine in patients with HUT-induced VVS compared with HUT-negative controls. 4, 7, [17] [18] [19] [20] However, the exact function of epinephrine in VVS is not completely understood. Does epinephrine act as a direct trigger of VVS or reflect a compensatory mechanism caused by hemodynamic stress? Nilsson et al 21 have shown that orthostatic levels of epinephrine are higher in patients with VVS evoked during the drug-free phase of HUT compared with patients in whom VVS was triggered by addition of Mean heart rate supine, bpm 67.2AE10.5
Mean heart rate standing 3 min, bpm 83.1AE16.5
Use of b-blockers, n (%) 17 (10.6)
Use of calcium channel blockers, n (%) 12 (7.5)
Use of RAAS antagonists, n (%) 24 (14.9)
Use of diuretics, n (%) 18 (11.2) Data are presented as meanAESD unless otherwise indicated. BP indicates blood pressure; IQR, interquartile range; RAAS, renin-angiotensin-aldosterone system. nitroglycerin, indicating an association between higher epinephrine levels and increased susceptibility to VVS. However, in that study the relation between the magnitude of epinephrine increase in syncope and the timing of the reflex was not assessed. Other studies 4, 19 have shown that epinephrine begins to rise in patients with HUT-induced drug-free VVS before any hemodynamic changes can be observed. This suggests that epinephrine directly affects the vasovagal reflex-triggering mechanism and is not merely a compensatory mechanism. To support this hypothesis, a smaller, more recent study 8 examined the relations between time to syncope and catecholamine concentrations and found that higher levels of supine and orthostatic epinephrine, but not norepinephrine, correlate with shorter time to syncope, suggesting a direct role of epinephrine in triggering VVS. Our study, including a much larger population of VVS patients, confirms the latter observation that a higher orthostatic, but not supine, epinephrine level on HUT correlates with shorter time to the onset of VVS reflex.
Vasopressin
Previous studies have shown vasopressin levels to be raised in patients with HUT-induced VVS compared with HUT-negative controls. 4, 9, 18, 22 Additionally, Nilsson et al 21 found that orthostatic CT-proAVP levels were higher in patients with VVS induced by drug-free HUT compared with patients in whom HUT required the addition of nitroglycerin to induce VVS; the latter observation suggests increased VVS susceptibility in the former subset of fainters. In terms of pathophysiology, vasopressin is believed to increase the sensitivity of cardiac baroreceptors, 23 an effect that is likely to promote the vasovagal reflex. Our study, in which greater CT-proAVP increase appeared to shorten time to HUT-induced VVS, supports the concept that AVP plays a role in VVS susceptibility. Data are reported as b-coefficient and standard error per 1 SD. CT-proAVP indicates C-terminal pro-arginine vasopressin; CT-proET-1, C-terminal pro-endothelin-1; HUT, head-up tilt test; MR-proADM, midregional fragment of pro-adrenomedullin; MR-proANP, midregional fragment of pro-atrial natriuretic peptide. *P<0.05. Vasopressin is released in response to hyperosmolarity and reduced blood volume and blood pressure, leading to water retention in renal collecting tubes and vasoconstriction. 24 Vasopressin acts as a backup system to the reninangiotensin and sympathetic systems, and when they are intact, it is not critical for hemodynamic stability. 24 If the latter vasopressin function is relevant in VVS, it implies that the vasopressin increase before syncope is a second-line compensation mechanism caused by hemodynamic instability. However, additionally, vasopressin can modulate its own effects by increasing vagal tone and decreasing sympathetic activity, [22] [23] [24] which suggests that it could also have a direct effect on VVS pathophysiology.
Adrenomedullin
Adrenomedullin (ADM) maintains the endothelial barrier function to prevent vascular leakage and edema. Moreover, ADM is released by systemic volume overload, and it has vasodilatory and natriuretic effects. 25 Previous, mostly small, studies on ADM levels have reported inconsistent results.
Rossler et al 26 found that ADM increases in healthy subjects during orthostatic stress. Plasek et al 27 reported no significant difference in ADM levels in a small study comparing HUT-positive patients with a HUT-negative control group. Hinghofer-Szalkay et al 28 observed no difference in baseline or orthostatic ADM levels in a small study of healthy subjects when presyncope was induced with HUT and lower-body negative pressure. Hamrefors et al 5 observed that in patients >40 years, lower supine MR-pro-ADM predicted asystolic VVS on HUT, although orthostatic levels of the biomarker were not assessed. They also reported a linear trend of low ADM levels in asystolic VVS, higher levels in noncardioinhibition VVS, and the highest levels in HUT-negative subjects, indicating increasing VVS severity with lower ADM levels. Supporting the latter observation, 5 the present study shows that higher baseline MR-proADM during HUT correlates with a longer time to syncope, which suggests a protective effect of ADM against the main VVS reflex triggers: diminishing intravascular volume and reduction of cardiac output. 29 
Systolic Blood Pressure
We observed that higher resting supine systolic blood presure correlates with longer time to syncope. This finding is not at all controversial because it is well known that afferent firing of baroreceptors and consequent sympathetic activation possibly leading to epinephrine spillover and VVS are dependent on the resting blood pressure level-the lower the systolic blood pressure, the higher the baroreceptor afferent activity. 32 
Limitations
The interpretation of findings in this study is subject to several limitations. First, the concept that earlier triggering of VVS during HUT is a reasonable model of events leading to the initiation of spontaneous VVS is as yet unproven. However, true spontaneous VVS does not lend itself to comparable evaluation. Second, neurohormones were assessed only at baseline and after 3 minutes of HUT, and further changes in levels of neurohormones might have occurred at the time of syncope or after syncope. Third, multiple other neurohormones not included in our studies and currently unmeasured may contribute to VVS. Finally, certain circulating neurohormones represent the "overflow" from sites of action (eg, synapses), and their functional role must be considered in that light.
Conclusions
In conclusion, our findings suggest that susceptibility to HUTinduced VVS is inversely related to age, higher supine systolic blood pressure, and a higher circulating level of adrenomedullin. During orthostasis, greater increase in epinephrine and vasopressin herald imminent onset of VVS. Together, these observations may assist development of new strategies for VVS prevention in patients experiencing frequent and unpredicted events.
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